Volume | 118,376 |
|
|||||
News | - | ||||||
Day High | 0.3501 | Low High |
|||||
Day Low | 0.3202 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Exicure Inc | XCUR | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.3322 | 0.3202 | 0.3501 | 0.3302 | 0.3352 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
281 | 118,376 | $ 0.3339621 | $ 39,533 | - | 0.30 - 1.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:48:44 | formt | 2,000 | $ 0.3253 | USD |
Exicure Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.85M | 8.65M | - | 0 | -16.91M | -1.96 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Exicure News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XCUR Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.4198 | 0.4397 | 0.3202 | 0.35867 | 121,422 | -0.0945 | -22.51% |
1 Month | 0.513 | 0.8549 | 0.30 | 0.4659369 | 918,475 | -0.1877 | -36.59% |
3 Months | 0.61 | 0.8549 | 0.30 | 0.4733908 | 320,238 | -0.2847 | -46.67% |
6 Months | 0.62 | 0.86 | 0.30 | 0.6052268 | 400,080 | -0.2947 | -47.53% |
1 Year | 1.20 | 1.50 | 0.30 | 0.5868828 | 337,447 | -0.8747 | -72.89% |
3 Years | 1.67 | 3.24 | 0.0846 | 0.3637793 | 2,632,734 | -1.34 | -80.52% |
5 Years | 2.20 | 3.84 | 0.0846 | 0.5162914 | 1,745,322 | -1.87 | -85.21% |
Exicure Description
Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. |